Tradestie Institutional Equity Comparison Engine
NTLA vs TWST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TWST Overall Edge
TWST Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus TWST at N/M Forward P/E and -31.9% operating margin (+23.2% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against TWST sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NTLA N/M vs TWST N/M Fwd P/E
Growth & Margin Winner
TWST
Op Margin -826.0% vs -31.9% ยท YoY -48.0% vs +23.2%
Momentum & Technical Winner
TWST
1Y +15.3% vs +254.0% ยท 52W Pos 20% vs 42%
Options & Structure Winner
TWST
BREAKDOWN (78th %ile IV) vs CONSOLIDATION (18th %ile IV)
NTLA
NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap
$1.5B
1M Return
-12.43%
1Y Return
+15.34%
Forward P/E
N/M
Unified AI Score
49.9 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 59.0
Mom 60.0
TWST
NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.85
-5.15% 1D
Market Cap
$7.6B
1M Return
-20.26%
1Y Return
+254.01%
Forward P/E
N/M
Unified AI Score
51.7 / 100
HOLD
Tech 40.0
Fund 56.0
Flow 68.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NTLA +15.34%
TWST +254.01%
Spread: +238.67 pp (TWST Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NTLA Revenue | TWST Revenue | NTLA Op. Margin | TWST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $30M | $30M | -298.6% | -277.5% | TWST |
| FY2019 | $40M | $50M | -246.8% | -200.1% | TWST |
| FY2020 | $60M | $90M | -235.5% | -155.5% | TWST |
| FY2021 | $30M | $130M | -810.4% | -115.4% | TWST |
| FY2022 | $50M | $200M | -879.0% | -115.3% | TWST |
| FY2023 | $40M | $250M | -1420.5% | -88.6% | TWST |
| FY2024 | $60M | $310M | -923.1% | -70.6% | TWST |
| FY2025 | $70M | $380M | -651.7% | -36.2% | TWST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NTLA | TWST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $7.6B | Larger Scale | TWST |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -48.0% | +23.2% | Higher Growth | TWST |
| Operating Margin (TTM) Profitability | -826.0% | -31.9% | Higher Margin | TWST |
| Net Profit Margin Profitability | 0.0% | -31.7% | Higher Margin | NTLA |
| Return on Equity (ROE) Capital Efficiency | -62.6% | -29.6% | Higher ROE | TWST |
| 52-Week Range Position Momentum | 20% ($8โ$18) | 42% ($23โ$220) | Stronger Trend | TWST |
| Beta / 30D Volatility Risk Regime | 2.30ฮฒ ยท 87% Vol | 3.15ฮฒ ยท 127% Vol | Lower Realized Risk | NTLA |
| Unified Institutional Score Composite Signal | 49.9 / 100 (HOLD) | 51.7 / 100 (HOLD) | Higher Composite | TWST |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NTLA vs TWST Buy Guide
NTLA
BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
78th %ile
IV Regime
Elevated (60thโ80th %ile)
TWST
CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
18th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NTLA nor TWST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.